Policy
HIV prevention research, clinical trials, and implementation take place in countries and communities that are shaped by laws, regulations, budgets, and policies enacted at local, national, and even international levels. These elements form the policy environment in which HIV prevention research and programming take place.
Policy and HIV prevention research and advocacy:
Enabling ethical, scientifically
sound clinical trials
Monitoring and advocacy of policy issues
related to HIV prevention research are critical
to ensuring that research is ethical,
scientifically rigorous, and sufficiently
supported with financial resources and
political will. National and local policies on
the design, approval and monitoring of trials
are the foundation for HIV prevention research.
The
Good Participatory Guidelines developed by
AVAC and UNAIDS are designed to provide
systematic guidance on the roles and
responsibilities of trial sponsors and trial
implementers towards participants and their
communities.
Ensuring financing for research
and future trials
Funding for HIV prevention research is another
key arena for policy-related advocacy. In the
US, advocates continue to pressure US lawmakers
to approve increased funding for the US
National Institutes of Health, the Centers for
Disease Control, the US Military HIV Research
Program and the US Agency for International
Development as the major funders of HIV
prevention research worldwide. In Europe,
advocates pressure the European Union and
national governments to increase investments in
HIV vaccine, microbicide and PrEP research.
Lower-resourced countries, such as South
Africa, Brazil and India, also contribute
financially and by supporting clinical trials
locally.
Supporting Research Coordination
for HIV prevention research
Research coordination is an important focus for
policy advocacy. Efficient use of limited
research funds is critical in this era of
limited public sector budgets. Research
coordination also ensures that research is
cross-cutting, synergistic and non-duplicative.
Research consortia can allow for data sating
across networks and borders. Advocacy in
support of strategic planning by national,
multilateral and international organizations
can provide important focus to HIV prevention
research.
Effecting change, protecting
rights
Communities can work collectively to challenge
and change laws harmful to human rights and HIV
prevention research. For example, advocates,
activists, and public-health professionals are
working in many countries to overturn laws
criminalizing homosexuality, HIV transmission
or provision of syringe exchange, two types of
legislation that obstruct a rights-based
response to HIV prevention.




